Atlas Trials

Pre-Approval Access Single Patient Request for Talquetamab in Relapsed or Refractory Multiple Myeloma

Clinical trial NCT05503550 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT05503550
Sponsor
Janssen Research & Development, LLC
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Relapsed or Refractory Multiple Myeloma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.